Day 5: Top Takeaways From ASCO25
Dr. John Sweetenham shares highlights from Day 5 of the 2025 ASCO Annual Meeting, including data from large trials in advanced malignant melanoma and mCSPC plus a new approach to first-line treatment for patients with multiple myeloma who are not transplant eligible.
Transcript
Hello, I'm Dr. John Sweetenham, the host of the ASCO Daily News Podcast, with my takeaways on selected abstracts from Day 5 of the 2025 ASCO Annual Meeting. My disclosures are available in the transcript of this episode.
The selected abstracts from this final day of ASCO25 include important new data from large…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.